doi.org/10.1016/s2213-2600(21)00134-x

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

..., Caicun Zhou
38
The Lancet Respiratory Medicine32.80
Volume: 9, Issue: 9, Pages: 1021 - 1029
Published: Jul 21, 2021
Paper Fields
Paper Details
Title
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
DOI
doi.org/10.1016/s2213-2600(21)00134-x
Published Date
Jul 21, 2021
Journal
The Lancet Respiratory Medicine
Volume
9
Issue
9
Pages
1021 - 1029
© 2025 Pluto Labs All rights reserved.